Table 2.
All Respondents | Disease Genetics Sites | Pharmacogenetics Sites | p-Value | |
---|---|---|---|---|
Gender | n = 285 | n = 208 | n = 77 | <0.0001 |
Male | 139 (49%) | 126 (61%) | 13 (17%) | |
Female | 92 (32%) | 75 (36%) | 17 (22%) | |
Unreported | 54 (19%) | 7 (3%) | 47 (61%) | |
Practice Setting | <0.0001 | |||
Academic | 145 (51%) | 121 (58%) | 24 (31%) | |
Community | 140 (49%) | 87 (42%) | 53 (69%) | |
Race | <0.0001 | |||
White | 135 (47%) | 125 (60%) | 10 (13%) | |
Black | 24 (8%) | 17 (8%) | 7 (9%) | |
Asian | 59 (21%) | 48 (23%) | 11 (14%) | |
Hispanic | 12 (4%) | 10 (5%) | 2 (3%) | |
Other/Unreported | 55 (19%) | 8 (4%) | 47 (61%) | |
Years in Practice | <0.0001 | |||
0–5 years | 124 (44%) | 63 (30%) | 61 (79%) | |
>5 years | 160 (56%) | 144 (69%) | 16 (21%) | |
Unreported | 1 (0.4%) | 1 (0.5%) | 0 |